Showing results (61-70 of 348) with videos related to
Sort By:
Pageof 35
Leukemia|July 4, 2008
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myelomaI Breitkreutz, M S Raab, S Vallet, et al.Current Cancer Drug Targets|September 22, 2011
Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignanciesK Podar, K C AndersonThe Oncologist|May 2, 2001
History of the development of arsenic derivatives in cancer therapyS Waxman, K C AndersonLeukemia|July 23, 2013
Association of response endpoints with survival outcomes in multiple myelomaS Lonial, K C AndersonHematology/Oncology Clinics of North America|February 1, 1997
Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myelomaG Teoh, K C AndersonTransfusion|February 1, 1996
Posttransfusion graft-versus-host disease in Japanese newbornsH Ohto, K C AndersonOncogene|July 27, 2007
A pivotal role for Mcl-1 in Bortezomib-induced apoptosisK Podar, S L Gouill, J Zhang, et al.Oncogene|June 6, 2017
Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistanceY Song, S Li, A Ray, et al.Blood|February 25, 1999
Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cellsD Chauhan, A Bharti, N Raje, et al.Pageof 35